274 related articles for article (PubMed ID: 18547089)
21. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
[TBL] [Abstract][Full Text] [Related]
22. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
23. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy.
Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN
Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
[TBL] [Abstract][Full Text] [Related]
25. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
26. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
Jin C; Bai L; Wu H; Tian F; Guo G
Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and in vitro release properties of morphine-loaded PLLA-PEG-PLLA microparticles via solution enhanced dispersion by supercritical fluids.
Chen F; Yin G; Liao X; Yang Y; Huang Z; Gu J; Yao Y; Chen X; Gao H
J Mater Sci Mater Med; 2013 Jul; 24(7):1693-705. PubMed ID: 23625317
[TBL] [Abstract][Full Text] [Related]
28. Dirhenium decacarbonyl-loaded PLLA nanoparticles: influence of neutron irradiation and preliminary in vivo administration by the TMT technique.
Hamoudeh M; Fessi H; Mehier H; Faraj AA; Canet-Soulas E
Int J Pharm; 2008 Feb; 348(1-2):125-36. PubMed ID: 17716842
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release.
Liggins RT; Burt HM
Int J Pharm; 2004 Sep; 282(1-2):61-71. PubMed ID: 15336382
[TBL] [Abstract][Full Text] [Related]
30. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
Lu J; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery.
Alipour S; Montaseri H; Tafaghodi M
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):521-9. PubMed ID: 20732796
[TBL] [Abstract][Full Text] [Related]
33. New Poly(3-hydroxybutyrate) Microparticles with Paclitaxel Sustained Release for Intraperitoneal Administration.
Bonartsev AP; Zernov AL; Yakovlev SG; Zharkova II; Myshkina VL; Mahina TK; Bonartseva GA; Andronova NV; Smirnova GB; Borisova JA; Kalishjan MS; Shaitan KV; Treshalina HM
Anticancer Agents Med Chem; 2017; 17(3):434-441. PubMed ID: 27141874
[TBL] [Abstract][Full Text] [Related]
34. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
[TBL] [Abstract][Full Text] [Related]
35. Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method.
Xiang Y; Xiao M; Han S; Xu S; Cao Y; Lv Z; Liu J; Liu J; Deng L; Dong A
J Biomater Sci Polym Ed; 2014; 25(11):1144-58. PubMed ID: 24894948
[TBL] [Abstract][Full Text] [Related]
36. Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluation.
Tang B; Fang G; Gao Y; Liu Y; Liu J; Zou M; Cheng G
Int J Pharm; 2014 Nov; 475(1-2):416-27. PubMed ID: 25218393
[TBL] [Abstract][Full Text] [Related]
37. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.
Lee LY; Wang CH; Smith KA
J Control Release; 2008 Jan; 125(2):96-106. PubMed ID: 18054107
[TBL] [Abstract][Full Text] [Related]
38. Holmium-loaded poly(L-lactic acid) microspheres: in vitro degradation study.
Zielhuis SW; Nijsen JF; Krijger GC; van het Schip AD; Hennink WE
Biomacromolecules; 2006 Jul; 7(7):2217-23. PubMed ID: 16827590
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
40. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
Dong Y; Feng SS
Int J Pharm; 2007 Sep; 342(1-2):208-14. PubMed ID: 17560058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
